RAS pathway influences the number of melanocytic nevi in Cardio-facio-cutaneous and Costello syndromes.

[1]  Kachiu C. Lee,et al.  Ethical outpatient dermatology care during the coronavirus (COVID-19) pandemic , 2020, Journal of the American Academy of Dermatology.

[2]  J. Grant-Kels,et al.  Dupilumab for the Treatment of Dyshidrotic Eczema in 15 Consecutive Patients. , 2020, Journal of the American Academy of Dermatology.

[3]  J. Ko,et al.  Dupilumab Treatment of Nummular Dermatitis: A Retrospective Cohort Study. , 2020, Journal of the American Academy of Dermatology.

[4]  L. Qi,et al.  Comparison of hair manifestations in cardio‐facio‐cutaneous and Costello syndromes highlights the influence of the RAS pathway on hair growth , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  Steven J. M. Jones,et al.  Genomic Classification of Cutaneous Melanoma , 2015, Cell.

[6]  D. Siegel,et al.  Dermatological findings in 61 mutation‐positive individuals with cardiofaciocutaneous syndrome , 2011, The British journal of dermatology.

[7]  M. Weinstock,et al.  Study of Nevi in Children (SONIC): baseline findings and predictors of nevus count. , 2008, American journal of epidemiology.

[8]  Pablo Rodriguez-Viciana,et al.  Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome , 2006, Science.

[9]  R. Hennekam,et al.  Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome , 2006, Nature Genetics.

[10]  Yukichi Tanaka,et al.  Germline mutations in HRAS proto-oncogene cause Costello syndrome , 2005, Nature Genetics.

[11]  S. Shvartsman,et al.  RASopathies: unraveling mechanisms with animal models , 2015, Disease Models & Mechanisms.

[12]  P. Boyle,et al.  Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. , 2005, European journal of cancer.